Does Insulin Glargine And Lixisenatide Interact with Epinephrine?
Insulin Glargine And Lixisenatide and Epinephrine have a moderate drug interaction according to U.S. FDA drug labeling data. Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose increases and increased glucose monitoring may be required. The mechanism involves decreases blood glucose lowering effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Insulin Glargine And Lixisenatide Class
- Insulin Analog
- Epinephrine Class
- alpha-Adrenergic Agonist
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Insulin Glargine And Lixisenatide and Epinephrine occurs because decreases blood glucose lowering effect. Clinically, this means sympathomimetic agent that may decrease the blood glucose lowering effect. dose increases and increased glucose monitoring may be required. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Insulin Glargine And Lixisenatide and your doctor is considering prescribing Epinephrine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider